Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: PDCO stock price vs CVS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CVS's multiple
Needs CVS P/E.
Implied fair value · at PDCO's multiple
Needs PDCO P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
16 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
PATTERSON COMPANIES, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
CVS HEALTH Corp · implied price per share
Bear
$43.35
Base
$58.49
Bull
$78.21
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HENRY SCHEIN INC
PDCO vs HSIC
OWENS & MINOR INC/VA/
PDCO vs OMI
CARDINAL HEALTH INC
PDCO vs CAH
BECTON DICKINSON & CO
PDCO vs BDX
Walgreens Boots Alliance, Inc.
PDCO vs WBA
UNITEDHEALTH GROUP INC
PDCO vs UNH
Walmart Inc.
PDCO vs WMT
Cigna Group
PDCO vs CI
HUMANA INC
PDCO vs HUM
Elevance Health, Inc.
PDCO vs ELV
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe PDCO’s superior margins and lower leverage will persist, then a relative long PDCO versus CVS stance is reasonable because PDCO’s ROIC and margin profile are clearly better despite the incomplete valuation data.
The provided valuation outputs are internally mixed: CVS-implied price range of $22.72-$145.47 is extremely wide, while the DCF range of $3.92-$5.31 is far below the implied P/E price of $137.06. That gap suggests the comparison is highly sensitive to methodology and likely driven by the fact that PDCO lacks a current price and several valuation multiples are unavailable.
Supporting Metrics
